Skip to content

The effect of Dendrobium ferruginum in the treatment of radiation oral mucositis in nasopharyngeal carcinoma and its improvement of oral microecology

The effect of Dendrobium ferruginum in the treatment of radiation oral mucositis in nasopharyngeal carcinoma and its improvement of oral microecology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000483
Enrollment
Unknown
Registered
2024-09-26
Start date
2022-11-30
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Experimental group:Compound vitamin B12 solution + Dendrobium officinale tea drink. Dendrobium officinale 12g (provided by Zhejiang Cancer Hospital Pharmacy), decocted to 600ml by pharmacy machine, di
Control group:Gargle with compound vitamin B12 solution 3 times/day. Do not gargle within 30 minutes after medication. Fast and water should be prohibited. Treatment for 1 month is a course of treatme

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age 30 to 50 years old; 2) Confirmed diagnosis of nasopharyngeal carcinoma by pathology; (3) Patients who meet the diagnostic criteria of radiation oral mucositis in Western medicine; (4) Patients without obvious oral pharyngitis symptoms and oral mucosal injury before radiotherapy; 5) Sign informed consent and agree to join the cohort.

Exclusion criteria

Exclusion criteria: 1) Serious diseases combined with non-malignant tumors will affect the patient's compliance or put the patient in a dangerous state; 2) Accompanying other anti-tumor therapies or participating in other clinical trials; Patients using antibiotics: included those who had received systemic high dose of antibiotics within 3 months before enrollment those who had long-term systemic use of antibiotics or those who had long-term use of antibacterial mouthwash. 4) Patients who use other drugs for oral mucositis at the same time; 5) Patients with Behcet's disease systemic lupus erythematosus diabetes and other diseases.

Design outcomes

Primary

MeasureTime frame
Immune factor;Oral flora;

Secondary

MeasureTime frame
TCM syndrome score;Acute radiation oral mucositis scale;Immune-related factor;Immune-related factor IL-10;Salivary flow rate;Immune-related factor IL-11;

Countries

China

Contacts

Public ContactAiqin Zhang

Zhejiang Cancer Hospital

zhanghaojianbb@163.com+86 137 7746 2976

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026